In Azierta, we are experts in pharmacoeconomic studies.
Currently, resources that may be spent in pharmacoeconomics expenditure are limited so it is necessary to rationalize their consumption and priorize in the allocation of these resources to the options with higher economic advantages.
Pharmacoeconomic studies will permit us to know what the efficiency of different therapeutic alternatives is, so they will help to determine the therapeutic options that we should use in routine medical practice.
We have different pharmacoeconomic studies:
- Cost-benefit analysis.
- Cost-effectiveness analysis.
- Cost-utility analysis.
- Cost-minimization analysis.
- Cost of disease studies.
They can be performed by using prospective designs (alongside clinical trials and observational studies), retrospective and predictive designs (by carrying out pharmacoeconomic models) and integrating in the different phases of clinical development programs of new medicines.